Skip to main content

Publisher: Wiley-Blackwell

Volume 40, Number 4, 1 December 2012

Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field
pp. 716-750(35)
Authors: Fatehi, Leili; Wolf, Susan M.; McCullough, Jeffrey; Hall, Ralph; Lawrenz, Frances; Kahn, Jeffrey P.; Jones, Cortney; Campbell, Stephen A.; Dresser, Rebecca S.; Erdman, Arthur G.; Haynes, Christy L.; Hoerr, Robert A.; Hogle, Linda F.; Keane, Moira A.; Khushf, George; King, Nancy M. P.; Kokkoli, Efrosini; Marchant, Gary; Maynard, Andrew D.; Philbert, Martin; Ramachandran, Gurumurthy; Siegel, Ronald A.; Wickline, Samuel

Favourites:
ADD
Favourites:
ADD

A Portrait of Nanomedicine and Its Bioethical Implications
pp. 763-779(17)
Authors: Hall, Rebecca M.; Sun, Tong; Ferrari, Mauro

Favourites:
ADD

What Is Unique About Nanomedicine? The Significance of the Mesoscale
pp. 780-794(15)
Authors: Khushf, George; Siegel, Ronald A.

Favourites:
ADD

Toward Correlation in In Vivo and In Vitro Nanotoxicology Studies
pp. 795-801(7)
Authors: Maurer‐Jones, Melissa A.; Haynes, Christy L.

Favourites:
ADD
Favourites:
ADD

Concepts of Risk in Nanomedicine Research
pp. 809-822(14)
Author: Hogle, Linda F.

Favourites:
ADD
Favourites:
ADD

Prudent Precaution in Clinical Trials of Nanomedicines
pp. 831-840(10)
Authors: Marchant, Gary E.; Lindor, Rachel A.

Favourites:
ADD
Favourites:
ADD

Handling Worker and Third‐Party Exposures to Nanotherapeutics During Clinical Trials
pp. 856-864(9)
Authors: Ramachandran, Gurumurthy; Howard, John; Maynard, Andrew; Philbert, Martin

Favourites:
ADD

INTRODUCTION: Research Ethics: Reexamining Key Concerns
pp. 865-866(2)
Authors: King, Nancy M. P.; Iltis, Ana S.

Favourites:
ADD

Bad Blood Thirty Years Later: A Q&A with James H. Jones
pp. 867-872(6)
Authors: Jones, James H.; King, Nancy M. P.

Favourites:
ADD

The Troubling Persistence of Race in Pharmacogenomics
pp. 873-885(13)
Author: Kahn, Jonathan

Favourites:
ADD

Ethical Dimensions of Disparities in Depression Research and Treatment in the Pharmacogenomic Era
pp. 886-903(18)
Authors: Parker, Lisa S.; Satkoske, Valerie B.

Favourites:
ADD

Practical Steps to Community Engaged Research: From Inputs to Outcomes
pp. 904-914(11)
Authors: Isler, Malika Roman; Corbie‐Smith, Giselle

Favourites:
ADD

Alive and Well: The Research Imperative
pp. 915-921(7)
Author: Dresser, Rebecca

Favourites:
ADD

Revolution or Reform in Human Subjects Research Oversight
pp. 922-929(8)
Author: Joffe, Steven

Favourites:
ADD
Favourites:
ADD

In Plain Sight: A Solution to a Fundamental Challenge in Human Research
pp. 970-989(20)
Authors: Shepherd, Lois; Riley, Margaret Foster

Favourites:
ADD

More Than Cheating: Deception, IRB Shopping, and the Normative Legitimacy of IRBs
pp. 990-996(7)
Authors: Spellecy, Ryan; May, Thomas

Favourites:
ADD

What Research Ethics Should Learn from Genomics and Society Research: Lessons from the ELSI Congress of 2011
pp. 1008-1024(17)
Authors: Henderson, Gail E.; Juengst, Eric T.; King, Nancy M. P.; Kuczynski, Kristine; Michie, Marsha

Favourites:
ADD

Medication Information for Patients with Limited English Proficiency: Lessons from the European Union
pp. 1025-1033(9)
Authors: Regenstein, Marsha; Andres, Ellie; Nelson, Dylan; David, Stephanie; Lopert, Ruth; Katz, Richard

Favourites:
ADD

Public Health and the Law
pp. 1034-1039(6)
Author: Hodge, James G.

Favourites:
ADD

Currents in Contemporary Bioethics
pp. 1040-1046(7)
Authors: McGuire, Amy L.; Wang, Melody J.; Probst, Frank J.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more